Ikarian Capital’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $348K | Buy |
+15,662
| New | +$348K | 0.07% | 71 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 123 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 127 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 98 |
|
|
2021
Q3 | – | Sell |
-21,553
| Closed | -$558K | – | 152 |
|
|
2021
Q2 | $558K | Buy |
21,553
+12,000
| +126% | +$311K | 0.05% | 131 |
|
|
2021
Q1 | $207K | Sell |
9,553
-90,447
| -90% | -$1.96M | 0.01% | 161 |
|
|
2020
Q4 | $2.15M | Buy |
100,000
+50,000
| +100% | +$1.07M | 0.09% | 71 |
|
|
2020
Q3 | $738K | Buy |
50,000
+45,419
| +991% | +$670K | 0.05% | 75 |
|
|
2020
Q2 | $102K | Buy |
+4,581
| New | +$102K | 0.01% | 76 |
|
|
2020
Q1 | – | Sell |
-143,000
| Closed | -$2.32M | – | 81 |
|
|
2019
Q4 | $2.32M | Buy |
+143,000
| New | +$2.32M | 0.38% | 17 |
|